Koers BetterLife Pharma Inc. Other OTC
Aandelen
BETRF
CA08772P2026
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 13,32 mln. 12,28 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -12 mln. -11,07 mln. | Nettowinst (verlies) 2023 | -9 mln. -8,3 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 139K 128K | Nettoschuld 2023 | 71,69K 66,11K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,26
x | K/w-verhouding 2023 |
-1,36
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 77,99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Moira Ong
DFI | Director of Finance/CFO | 49 | 26-12-10 |
Chief Operating Officer | 67 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ahmad Doroudian
CEO | Chief Executive Officer | 63 | 17-09-07 |
Robert Metcalfe
BRD | Director/Board Member | 84 | 21-01-20 |
Wolfgang Renz
BRD | Director/Board Member | 54 | 05-02-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 118 mld. | |
+11,60% | 106 mld. | |
-4,68% | 24,28 mld. | |
-0,82% | 21,96 mld. | |
-10,12% | 18,16 mld. | |
-42,12% | 16,37 mld. | |
-17,47% | 15,56 mld. | |
+2,77% | 13,63 mld. | |
+34,58% | 12,27 mld. |